• Reveromycin A, EvoPure� packaged and labeled in glass vial.

click on thumbnail to zoom
SKU: R022

Size  
Quantity:
  Click 'Bulk Order' for 10 or more
Price: make selection(s)
Description
Reveromycin A, the dominant analogue of a complex of spiroketals isolated from a Streptomyces sp., is an inhibitor of the mitogenic activity of EGF. Reveromycin A displays antiproliferative behaviour against human cell lines KB and K562, as well as potent antifungal activity. More recently it has been shown to induce apoptosis in osteoclasts thus inhibiting bone resorption.

Reveromycin A is soluble in ethanol, methanol, DMF and DMSO.

    CAS Number

    134615-37-5

    Molecular Formula

    C36H52O11

    Molecular Weight

    660.8

    Mechanism of Action

    Reveromycin A is a G1 phase cell cycle inhibitor, selectively inhibiting isoleucyl-tRNA synthetase.

    Storage Conditions

    -20°C

Specifications

    Appearance

    Tan Lyophilisate

References

    References

    Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Woo J.T. et al. Proc Natl Acad Sci USA. 2006, 103, 4729.

    Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Muguruma H. et al. Clin Cancer Res. 2005, 11, 8822.

    Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A. Miyamoto Y., et al. , J. Biol. Chem., 2002, 277, 28810. 

    Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities. Takahashi H., et al. , J. Antibiot., 1992, 45, 1414.

Other Items In This Category